Tianjin Lisheng Pharmaceutical (002393.SZ) has received the registration certificate for Fluconazole tablets.
Livzon Pharmaceutical (002393.SZ) announced that the company has received the "Drug Registration Certificate" for the 0.2g specification of Fudeconazole tablets and the "Drug Registration Certificate" for the 50mg specification of Fudeconazole tablets issued by the National Medical Products Administration. The above-mentioned drugs have passed the drug market authorization application. Fudeconazole tablets are a broad-spectrum triazole antifungal drug.
Tianjin Lisheng Pharmaceutical (002393.SZ) announced that the company has received the "Drug Registration Certificate" for the 0.2g specification of Fulekangzuo tablets and the "Drug Registration Certificate" for the 50mg specification of Fulekangzuo tablets issued by the National Medical Products Administration. The above-mentioned drugs have passed the drug market approval application. Fulekangzuo tablets are a broad-spectrum triazole antifungal drug.
Related Articles
Lingbao Gold issued 6.6181 million shares due to the conversion of convertible bonds.
JD LOGISTICS (02618) announced its performance for the year 2025, with a net profit attributable to shareholders of 6.647 billion yuan, representing a year-on-year growth of 7.2%.
GEMDALE PPT (00535) February contract sales totaled approximately 306 million RMB, a decrease of 63.13% year-on-year.
Lingbao Gold issued 6.6181 million shares due to the conversion of convertible bonds.
JD LOGISTICS (02618) announced its performance for the year 2025, with a net profit attributable to shareholders of 6.647 billion yuan, representing a year-on-year growth of 7.2%.
GEMDALE PPT (00535) February contract sales totaled approximately 306 million RMB, a decrease of 63.13% year-on-year.
RECOMMEND
